MedTrace Logo

Compare Effects of EpiCor and Vitamin C to Vitamin C Alone on the Common Cold or Influenza in Healthy Children

NCT04093206 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 221

Last updated 2019-09-17

No results posted yet for this study

Summary

The purpose of the clinical study is to evaluate efficacy of regular daily, 12 weeks, consumption of EpiCor syrup containing EpiCor and vitamin C in non-vaccinated children 1-6 years old on preventing episodes of the common cold and flu as well as on the severity of symptoms of the common cold and flu in case of their occurrence. Additionally, the study aims to assess the effect of EpiCor on the use of prescription drugs and changes of a selected biochemical marker. This is a double-blind, randomized, controlled multi-center clinical trial.

Conditions

  • Signs and Symptoms, Respiratory

Interventions

DIETARY_SUPPLEMENT

EpiCor and Vitamin C

One daily dose

DIETARY_SUPPLEMENT

Vitamin C

One daily dose

Sponsors & Collaborators

  • Clinres Farmacija d.o.o.

    collaborator INDUSTRY

  • PharmaLinea d.o.o.

    collaborator UNKNOWN

  • Diagnostic Laboratory Medicare PLUS d.o.o.

    collaborator UNKNOWN

  • Embria Health Sciences

    collaborator UNKNOWN

  • Cargill

    lead INDUSTRY

Principal Investigators

  • Alojz Ihan · University of Ljubljana

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-22
Primary Completion
2019-03-28
Completion
2019-03-28

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04093206 on ClinicalTrials.gov